- Shengnuo Biology main business is the R & D, production and sales of peptide preparations and APIs, as well as providing pharmaceutical research and customized production services.
- According to the data released by FDA of the United States, more than 70% of the newly added major peptide generic drug substance DMF were registered in China and India from 2015 to 2019.
- At present, the products of Shengnuo Biology mainly focus on peptide raw materials and generic drugs.
- In addition, Shengnuo Biology enfoviride API is mainly exported to Mexico, which has not yet been sold in China. Etibante preparation is in the approval stage in China.
Shengnuo Biology main business is the R & D, production and sales of peptide preparations and APIs, as well as providing pharmaceutical research and customized production services.
Its products cover the fields of immune system diseases, cancer, cardiovascular, chronic hepatitis B, diabetes, AIDS and obstetric diseases. As of the disclosure date of the prospectus, sinobio has 7 polypeptide preparation products, all of which have obtained domestic approval.
Among them, enfoviride for injection and carbetoxine injection are the first imitative polypeptide drugs in China. Sinobio has mastered the large-scale production technology of 15 varieties of API: 7 kinds of polypeptide API production approval documents have been obtained in the domestic market; 8 kinds of DMF activation records in the United States have been obtained in the foreign market.
According to the data released by FDA of the United States, more than 70% of the newly added major peptide generic drug substance DMF were registered in China and India from 2015 to 2019.
According to the data of FDA of the United States in September 2019, among the top 30 polypeptide drugs sold in the world, Shengnuo Biology has obtained 6 kinds of FDA activation records, ranking the eighth in the world and the third in China.
According to the statistics of QY research, the global peptide drug market scale was about 15.2 billion US dollars in 2010 and 28.5 billion US dollars in 2018, with an annual compound growth rate of 8.17%.
It is estimated that the market size will reach US $49.5 billion in 2027, with an annual compound growth rate of 7.9%. According to the data released by Zhiyan consulting, the sales volume of polypeptide drugs in China increased from 5.6 billion yuan in 2009 to 29.56 billion yuan in 2017, with an average annual compound growth rate of 23.12%.
At present, the products of Shengnuo Biology mainly focus on peptide raw materials and generic drugs.
Among them, bevaludine API was registered in DMF of the United States in 2012 and is the first supplier of Fresenius.
It is understood that in 2019, the sales volume of bevaludine in the U.S. market is $117 million, with Fresenius accounting for 30.83%. Carbetoxol was listed in 2016, and the main competitors in the domestic market include Huiling pharmaceutical and Hanyu pharmaceutical.
According to the data from the Internet, the domestic market share of sinobio carbetoxine preparations will be 20.97% in 2019. In 2018, atosiban acetate preparation obtained the registration approval and started production and sales.
Domestic market competition enterprises include Huiling pharmaceutical and Hainan Zhonghe. According to the data of the Internet, the domestic market share of atosiban preparation of Shengnuo Biology acetate is 2.82% in 2019.
The domestic market competition of somatostatin preparation, thymopentin raw material drug and new thymus preparation is fierce.
At present, Shengnuo Biology mainly sells raw material drugs in China, and the main competitive enterprises include suhao Yiming and Suzhou Tianma. In the aspect of octreotide acetate raw materials and preparations, Shengnuo Biology products were launched late and are still in the market development stage, with a market share of 0.77%.
In addition, Shengnuo Biology enfoviride API is mainly exported to Mexico, which has not yet been sold in China. Etibante preparation is in the approval stage in China.
For sale, buy peptides, purchase peptides, and buy peptides online, you can find the Chinese peptide company:
Shengnuo Biotechnology is a high-tech China polypeptide manufacturers,who has over 19 years experience for the biotechnology .Our Products involve peptide raw materials,polypeptide drug.
Our 0 defect has passed the FDA certification, and has become the first-class professional polypeptide drug and product development and large-scale production and export industry in China .
Our service scope：peptide synthesis、peptide hormones、peptide medicine、beauty peptide、peptide medicine product、peptide technology transfer、peptide technology service、peptide large-scale production、export of peptide
Thymopentin for Injection、 Thymalfasin for Injection 、 Bivalirudin 、Bulk Drug、 Liraglutide ……